Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Outcome of Board Meeting (EGM on June 27, 2015)

 Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2015, inter alia, ha approved and taken on record the following:1. Increase of equity investment percentage in the Company to 49% to Foreign Institutional Investors (FIIs) / Foreign Portfolio Investors etc.2. Further issue of shares or Convertible Securities of any nature in the form of Private Placement, Qualified Institutional...
22-05-2015
Bigul

Announces Q4 & FY15 results

 Natco Pharma Ltd has announced the following results for the quarter & year ended March 31, 2015:The Unaudited results for the Quarter ended March 31, 2015The Company has posted a net profit after deferred tax expenses/Reversal of Rs. 651.00 million for the quarter ended March 31, 2015 as compared to Rs. 263.40 million for the quarter ended March 31, 2014. Total Income has increased from Rs. 1626.20 million for the quarter ended March...
22-05-2015
Bigul

Annual report for Natco Pharma Ltd. for FY-2015
22-05-2015
Bigul

Board Meeting on May 22, 2015

 With reference to the SEBI Circular dated May 11, 2015, Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 22, 2015 inter alia, will consider the following:1. Formulation of Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive information pursuant to Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and...
18-05-2015
Bigul

Natco mulls raising FPI stake

 Natco Pharma will increase the equity investment percentage in the company for foreign portfolio investors to 49 per cent. The companys board, which will meet on May 22 to approve the una...
13-05-2015
Bigul

FY15 results on May 22, 2015

 Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 22, 2015, to consider the following :1. Approval of the unaudited financial Results for the quarter ending March, 2015 along with Audited Annual Accounts for the year 2014-2015.2. Approval of increase of equity investment percentage in the Company to 49% to Foreign Institutional Investors (FIIs) / Foreign Portfolio Investors etc....
12-05-2015
Bigul

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 Natco Pharma Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
23-04-2015
Bigul

Natco Pharma drops after Teva's offer to buy Mylan

 Teva Pharmaceutical Industries Ltd on Tuesday made an unsolicited $40 billion offer for smaller rival Mylan
22-04-2015
Bigul

Natco Pharma Falls as Teva Bids for Mylan

 Natco Pharma has a partnership with Mylan for marketing the generic version of Capaxone on a profit-sharing basis. The Teva-Mylan deal, if materialises, may not have much negative impact on Natco Phar...
22-04-2015
Bigul

Natco Pharma up 60% so far this year; here's why

 Hopes of some high value launches over the next few months have also boosted sentiment in the stock. It has risen as much as 60% so far in 2015.
11-04-2015
Next Page
Close

Let's Open Free Demat Account